©2003 Accordant Steven K. Schelhammer Founder and President Through Integrated Disease Management Managing Costly Chronic Conditions.

Slides:



Advertisements
Similar presentations
DDRS Health Homes Initiative: Meeting the Triple Aim through Care Coordination. Shane Spotts Director, Indiana Division of Rehabilitation Services May.
Advertisements

Solution in Drug Plan Management 2011 September 8, 2011 Basil Rowe Vice President, Total Rewards and Shared Services Shoppers Drug Mart
Disease State Management The Pharmacist’s Role
©2011 Walgreen Co. All rights reserved. Georgia Hospital Association Reducing Readmission Learning Collaborative November 7, 2012.
4th Annual Investor Conference May 16, 2001 HEALTH PLANS DIVISION Panel Discussion: Contributing Value to Cost of Care.
SEHCB Educational and Training Conference Alere March 3, 2009 Columbus, OH.
Drug Utilization Review (DUR)
Keeping it Simple: Using IVR to Enhance Wellness Janelle Howe Sr. Director, Health Enhancement HealthCare Partners Medical Group Co-Investigator, HealthCare.
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
Heal Teach Discover Serve Geisinger Value 1 Transitions of Care/Personal Health Navigator January 31, 2009.
America’s Health Insurance Plans Health Insurance Plans Approaches to Asthma Management: 2006 Assessment Supported through a cooperative agreement with.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Community-based Falls Prevention Falls Preconference Session August 20, 2007 Pam Van Zyl York, MPH, PhD, RD, LN Minnesota Department of Health.
MAMSI Health Plans 2003 (c)1 Evaluating Disease Management Return on Investment “Lessons Learned” Sally J. Duran Disease Management Summit May 11, 2003.
It’s A Success! Achieving Cost-Effective Disease Management in CHF Sherry Shults, RN BSN CIO South Carolina Heart Center.
Fairview Specialty Pharmacy
© HHL Group March 2013 Ray Wihapi 14 November 2013 Te Whiringa Ora.
The Big Puzzle Evolving the Continuum of Care. Agenda Goal Pre Acute Care Intra Hospital Care Post Hospital Care Grading the Value of Post Acute Providers.
Sutter Care Coordination Program (SCCP) Supporting Patients and Practitioners in Optimizing Health.
Strengthening partnerships: A National Voluntary Health Agency’s initiatives in managed care Sarah L. Sampsel, MPH* Lisa M. Carlson, MPH, CHES* Michele.
Care Coordination What is it? How Do We Get Started?
On the Horizon for Affordable Housing: What the Research Says Alisha Sanders LeadingAge Center for Housing Plus Services LeadingAge Maryland Annual Conference.
Community Care and Wellness for Seniors
2 AMERIGROUP Community Care Entered Maryland market in 1999 Largest MCO in Maryland Serving over 143,000 members in Baltimore City and 20 counties in.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
AN EVOLVING SUCCESS STORY THE INTEGRATION OF CARE COORDINATION :
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
Harnessing the Power of Predictive Modeling Future Trends.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Alliance for Better Health Care Alliance for Better Health Care, LLC 1.
Occupational Health. Occupational Medicine Recognized Specialty Since 1949 Combines Clinical Skills With Toxicology, Epidemiology, Safety, Rehabilitation,
Exclusively serving Indiana families since Population Health Management from the Managed Care Entity Perspective IPHCA Annual Conference 2015.
DataBrief: Did you know… DataBrief Series ● February 2013 ● No. 38 Medicare Spending for Beneficiaries with Severe Mental Illness and Substance Use Disorder.
Integrating Behavioral Health and Primary Care
Incorporating Disease Management Into Your Long-Term Health Care Strategy Gregory R. Nickell, Director, Health Care Services State Teachers Retirement.
Managing Exercise in Persons with Multiple Chronic Conditions Chapter 04.
Population Health Janet Appel, RN, MSN Director of Informatics and Population Health.
Quality Improvement and Care Transitions in a Medical Home Maryland Learning Collaborative May 21, 2014 Stephanie Garrity, M.S., Cecil County Health Officer.
Predictive Modeling Strategies for Disease Management Programs December 14, 2007 The National Predictive Modeling Summit Steve Johnson,
Redefining Care for Seniors and the Chronically Ill Gary German President & CEO New York, NY
Disease Management & Special Needs Plans May 11, 2006.
Disease Management in Managed Care  Next generation of “Managed Care” –Disease Management for populations –Advanced Care Management for Individuals 
Case Management. What? Who? Why? Areas of activities Contents.
HOUSTON METHODIST POPULATION HEALTH MANAGEMENT
Wellness Coalition America Fully Integrated Solution April 2014.
Approaches to Slowing Cost Growth in Public Programs State Coverage Initiatives National Meeting August 5, 2010 Nikki Highsmith Center for Health Care.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
Falls and Fall Prevention. Prevalence of Falls in Older Adults  33% of older adults fall each year  Falls are the leading cause of fatal and nonfatal.
PROPRIETARY & CONFIDENTIAL 1 Specialty Pharmacy Trends and AcariaHealth Specialty Pharmacy Solution AcariaHealth Presentation April 6, 2015.
PREVENTION PLUS Brought to you by:. As of January 1, 2015, CMS has started paying MONTHLY reimbursement for care coordination services to eligible Medicare.
1 million Ga. Medicaid & PeachCare patients to move to HMOs (CMOs); 100,000 elderly & disabled to enter disease management.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Chapter 9 Case Management Copyright © 2015, 2011, 2007, 2001, 1997, 1993 by Saunders, an imprint of Elsevier Inc.
What Will it Take for DM to Demonstrate an ROI? Ariel Linden, DrPH, MS President, Linden Consulting Group
Medication therapy management
Wireless Access SSID: cwag2017
CONTROLLING THE COSTS OF HEMOPHILIA
Education program ( system). Education program ( system)
Nursing Intervention Classifications
Clinical Pharmacy II.
Introduction to Clinical Pharmacy
Changing Specialty Distribution to Clinical Management Models
Foster Care Managed Care Program
Bending the Cost Curve A Case for Integration.
Specialty Pharmacy Management
Alliance Complete Care Model
National Association of Medicaid Director’s Fall Conference
Pharmacy – Fully Insured versus Self Funding
Risk Stratification for Care Management
Presentation transcript:

©2003 Accordant Steven K. Schelhammer Founder and President Through Integrated Disease Management Managing Costly Chronic Conditions

©2003 Accordant Managing Costly Chronic Conditions Agenda  Costly chronic conditions  Specialized disease management  Predictive modeling  Integrated care  Care coordination  Interventions  Results

©2003 Accordant Specialty Drug Costs Per Patient Per Year Growth Hormone Deficiency $18,000 Hepatitis C $24,000 Infertility $18,000-20,000 Multiple Sclerosis $15,000 Oncology, BMT HIV/AIDS $5,000-10,000 Hemophilia $200,000 + Rheumatoid Arthritis $15,000 + Gaucher Disease $250,000 Pulmonary Hypertension $30, ,000 Costly Chronic Conditions Examples of Their Direct Impact on Spend

©2003 Accordant Costly Chronic Conditions Are Complex, Unique and Progressive  Require:  Specialized expertise  Patient self-management  Dynamic interventions to meet varying complications  Support to prevent crises  Result in:  High costs for inpatient hospitalization  Expensive specialty drugs utilization  Patient identification difficulty, due to many false positives  Progression of expense over time

©2003 Accordant 5.7% 9.6% 6.9% 0% 5% 10% 15% 20% $0 $300 $600 $900 $1,200 $1,500 Avg. PMPM Chronic Diseases CMS- Reported Inflation Costly Chronic Conditions Significant Total Cost Trend For Conditions Source: Accordant Health Services, Inc. Medical cost increases for unmanaged chronic diseases average 15.6 percent, surpassing the rate of inflation

©2003 Accordant Specialized DM: Solution  Improves health and lower costs, through:  Predictive modeling –Supports patient identification  Case management –Nurses provide patient education and compliance monitoring  Disease management expertise –Serving patients with chronic, complex, progressive diseases  Specialty pharmacy services –Integrated workflow, reporting and intervention

©2003 Accordant Specialized DM: Predictive Modeling Leads a Targeted Approach  Why predictive modeling?  Use when the correlation between near-term costs and disease diagnosis is weak, like COPD, diabetes or asthma But, predictive modeling is not enough …  Standard predictive models can’t identify complex, chronic patients  For example, one client’s former predictive modeling vendor was only able to identify 161 of over 1,900 high- cost patients  For co-hort of Accordant diseases, the diagnosis IS the prediction of high-cost patients

©2003 Accordant Specialized DM: Predictive Modeling Population Management Note: Population migration analysis, AHS vs. MCO. Figure shows percent of population at or above the “top” cost threshold. 70% of today’s high-cost patients were not high-cost 2 years ago

©2003 Accordant Source: AHS-MCO Unmanaged: 95% of Patients Exceed the 90 th Cost Percentile  For Accordant diseases, diagnosis is the best predictor of future near-term costs  Patients exceed 90 th cost percentile  8 months, on average  Based on 24-month continuous enrollment Specialized DM: Predictive Modeling A 24-month Cost Threshold

©2003 Accordant Specialized DM: Integrated Care  Address entire condition and its typical course with population-based approach to:  Minimize the magnitude of acute events and high cost cases  Reduce the frequency of predictable events and high-cost cases PMPM Least Costly Population DM opportunity PMPM Every patient with the condition is eligible Most Costly

©2003 Accordant Solid Bidirectional Information Flow Nonexistent or One-Way Information Flow As-Needed Information Flow  Incompatible Systems  Mis-Aligned Incentives Opportunity for Specialty Pharmacy Integration Benefits Information flow from typical Specialty Rx vendors Accordant Health Services DM Coordination MCO Info Patient Info Physician Info Homecare Info Provider Info Specialty Pharmacy Info  Operational Priorities  Competitive Concerns

©2003 Accordant Solid Bidirectional Information Flow Solid Bi-directional Information Flow As-Needed Information Flow Accordant DM with AdvancePCS Specialty RX Better Communication and Service DM Coordination MCO Info Patient Info Physician Info Homecare Info Provider Info Specialty Pharmacy Info  Compatible Systems  Aligned Incentives  Consistent Operational Priorities  No Competitive Concerns

©2003 Accordant Specialized DM: Integrated Care with Specialty Pharmacy  Increases program savings by an additional 20% and ROI by 40%  Greater control over specialty drug spend with patient steerage and standard therapy guidelines  Enhanced patient services with single point of contact  More effective real-time interventions  Example  A large health plan client  Implemented integrated specialty pharmacy service  Realized $600K in savings to date  On track for an additional 20% savings

©2003 Accordant Specialized DM: Care Coordination  Benefits review  Facilitation between patient, physician, health plan and vendors  Coordination includes home infusion and therapies, DME, PT, OT  Same benefits review, coordination, facilitation with comorbid conditions, as with the DM program they are enrolled in

©2003 Accordant Specialized DM: Care Coordination with Physicians  Offers physician support in caring for patients  Highly trained and experienced patient support partner  Helps promote treatment compliance  Coordinates an array of complex care and services that ordinarily bewilder patients  Improves health outcomes by providing additional service and support to the physician

©2003 Accordant Specialized DM: Interventions Research & Development  Research natural history of the disease and develop construct  Identify and rank significant complications and their associated costs  Baseline cost analysis  Assess significant risks and match proven strategies to prevent problems and complications Medical guideline: Strategy-intervention grid

©2003 Accordant Specialized DM: Interventions Preventing Complications  Risk stratification, each with their own interventions  Multiple sclerosis: –Exacerbations –UTI –Falls with fractures –Skin breakdown  Rheumatoid arthritis: –Flares –Infections –Falls with fractures –GI bleeding  Assess and monitor closely

©2003 Accordant Specialized DM: Interventions Promoting Patient Self-Management  Access to general information and assessments  Education about disease, medications and therapies  Better communication with the health care team  Compliance with the treatment plan  Skills development assistance including coping, lifestyle and service coordination

©2003 Accordant Specialized DM: Interventions Data Analysis  Analysis of integrated claims and patient-reported data on MS flares  Findings: –Antidepressant users were 3 times more likely to have a flare –Patients with a concurrent infection are 1.5 times more likely to have a flare –Incidence and frequency of flares are related to disease progression  Results: –Investigating the link between these associations and flares

©2003 Accordant Specialized DM: Intervention Example Promoting Better Self-Management Skills for MS Goal: Decrease admissions to hospital for urinary tract infection and Pyelonephritis -- Ranked # 2 for hospital admissions  Assess patient’s knowledge of:  UTI and its major symptoms  Symptoms of spastic “neurogenic” bladder  What to do if they develop acute Sx’s  Intervene with:  Education  Assessment of clinical status  Facilitate appointments with physician,  Alert the physician of acute symptoms and untreated spastic neurogenic bladder Guidelines: American Academy of Neurology and NMSS

©2003 Accordant Specialized DM: Intervention Example Falls with Fractures are Common for RA Patients Goal: Decrease falls and fractures that lead to hospitalization  Assess:  Risk of falls with mobility scales such as HAQ for rheumatology conditions.  Individual risks (lives alone, frequent trips to bathroom, etc)  Risk of osteoporosis (steroids, cytotoxic drugs)  Intervene with:  Education to prevent falls  Arrange home safety evaluation  Education about use of Calcium and Vitamin D  Alert physician for preventive medications for osteoporosis  Monitor for compliance with medications Guidelines: American Academy of Rheumatology, Osteoporosis Foundation

©2003 Accordant Specialized DM: Intervention Example Overutilization Among Hemophilia Patients Goal: Reduction of product overutilization  Manage by:  Preventing bleeding episodes  Minimizing the number of treatments needed to stop a bleed  Monitoring inventory/deliveries compared to prescription  Providing competitively priced products with aligned incentives  Intervene with:  Patient education  Behavior modification  Competitively-priced fulfillment of factor concentrates Guidelines: Hemophilia Treatment Center/National Hemophilia Foundation

©2003 Accordant Specialized DM: Intervention Promoting Drug Safety  Proactive interventions (education)  Patient pharmacy communications  Safe medicine practice at home  Safe medicine practice at hospital  Reactive intervention (monitoring)  Drug interactions  Contraindicated drugs  Medication duplications

©2003 Accordant MG-3 Source: Assessment Data through 6/30/2002 (95% CI Shown) Percent Carrying AHS Medication List 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Percent Length of Time in Program (LOTIP) by Qtr Results: Value Ensuring That Myasthenia Gravis Patients Carry a List of Contraindicated Drugs

©2003 Accordant Eligible members - Excluding members that have died, members for whom coverage is secondary, and members covered by another disease management organization. All Diseases Based on a specific client experience. Claims incurred through May Results: Value Comparing Pre and Post Cost Trends PMPM Length of Time in Program (LOTIP) Monthly Preprogram PMPM cost Post program PMPM cost PMPM

©2003 Accordant Based on a specific client experience. Claims incurred through May LOTIP: Length Of Time In Program Eligible members - Excluding members that have died, members for whom coverage is secondary, and members covered by another disease management organization. All Diseases Results: Value Comparing Preprogram Hospital Admit Costs Length of Time in Program (LOTIP) monthly Utilization Preprogram hospital admits / 100 Post program cost / 100